Management of progressive brain metastases in patients (pts) with relapsed germ-cell tumor (GCT) treated with salvage high-dose chemotherapy (HDCT).

被引：0
|
作者：
King, Jennifer
Abonour, Rafat
Hassoun, Rebecca
Althouse, Sandra K.
Salous, Tareq
Hanna, Nasser H.
Einhorn, Lawrence H.
Adra, Nabil
机构：
[1] Indiana Univ, Simon Comprehens Canc Ctr, Indianapolis, IN USA
[2] Indiana Univ, Simon Canc Ctr, Indianapolis, IN USA
[3] Indiana Univ, Melvin & Simon Comprehens Canc Ctr, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5036
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey
    Al-Ezzi, Esmail M.
    Zahralliyali, Amer
    Hansen, Aaron R.
    Hamilton, Robert J.
    Crump, Michael
    Kuruvilla, John
    Wood, Lori
    Nappi, Lucia
    Kollmannsberger, Christian K.
    North, Scott A.
    Winquist, Eric
    Soulieres, Denis
    Hotte, Sebastien J.
    Jiang, Di Maria
    CURRENT ONCOLOGY, 2023, 30 (07) : 6166 - 6176
  • [32] Multicenter analysis of high-dose chemotherapy (HDCT) regimens for the treatment of patients (pts) with recurrent germ cell tumors (GCTs).
    Chehrazi-Raffle, Alex
    Shodiya, Michael Olufemi
    Maldonado, Edward
    Othman, Tamer
    Ebrahimi, Hedyeh
    Carrillo, Regina Barragan
    Li, Xiaochen
    Rock, Adam
    Tripathi, Abhishek
    Pal, Sumanta Kumar
    Dorff, Tanya B.
    Zhumkhawala, Ali
    Hoeg, Rasmus
    Oliai, Caspian
    Olin, Rebecca L.
    Mei, Matthew Genyeh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] First-line high-dose chemotherapy ± radiation therapy in patients with metastatic germ-cell cancer and brain metastases
    Kollmannsberger, C
    Nichols, C
    Bamberg, M
    Hartmann, JT
    Schleucher, N
    Beyer, J
    Schöffski, P
    Derigs, G
    Rüther, U
    Böhlke, I
    Schmoll, HJ
    Kanz, L
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 553 - 559
  • [34] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Anja Lorch
    Jörg Beyer
    World Journal of Urology, 2017, 35 : 1177 - 1184
  • [35] Significance of high-dose chemotherapy (HDCT) for male germ cell tumors
    Lorch, A.
    Beyer, J.
    Bokemeyer, C.
    ONKOLOGE, 2013, 19 (07): : 568 - 572
  • [36] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Lorch, Anja
    Beyer, Jorg
    WORLD JOURNAL OF UROLOGY, 2017, 35 (08) : 1177 - 1184
  • [37] Conventional versus high-dose salvage chemotherapy for relapsed testicular germ cell tumours
    Oing, Christoph
    Hentrich, Marcus
    AKTUELLE UROLOGIE, 2024, 55 (06) : 543 - 548
  • [38] High-Dose Chemotherapy in Relapsed or Refractory Metastatic Germ-Cell Cancer: The Scotland Experience
    Tan, Yun Yi
    Al-Bubseeree, Bahaa
    Irvine, David
    MacDonald, Graham
    McQuaker, Grant
    Parker, Anne
    Waterston, Ashita
    White, Jeff
    CLINICAL GENITOURINARY CANCER, 2019, 17 (02) : 125 - 131
  • [39] The role of High-Dose Chemotherapy (HDCT) in patients with relapsed pure seminoma
    Rick, O
    Siegert, W
    Schwella, N
    Dubiel, M
    Krusch, A
    Beyer, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S33 - S33
  • [40] Impact of response to induction chemotherapy (CT) and prior paclitaxel (TXL)-based CT on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT) in the modern era: An EBMT Solid Tumors Working Party study.
    Necchi, Andrea
    Miceli, Rosalba
    Bregni, Marco
    Oechsle, Karin
    Kanfer, Edward
    Massard, Christophe
    Flechon, Aude
    Laszlo, Daniele
    Arpaci, Fikret
    Wuchter, Patrick
    Crysandt, Martina Margrit
    Unal, Ali
    Nagler, Arnon
    Wahlin, Anders
    Michieli, Mariagrazia
    Pflueger, Karl-Heinz
    Ringhoffer, Mark
    Badoglio, Manuela
    Pedrazzoli, Paolo
    Lanza, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345